Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia with high heterogeneity in the western world. Thus, investigators identified a number of prognostic biomarkers and scoring systems to guide treatment decisions and validated them in the context of immunochemotherapy. A better un...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Xiaoya, Zhang, Ya, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487566/
https://www.ncbi.nlm.nih.gov/pubmed/32939265
http://dx.doi.org/10.1186/s40364-020-00222-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487566/
https://www.ncbi.nlm.nih.gov/pubmed/32939265
http://dx.doi.org/10.1186/s40364-020-00222-3

Ejemplares similares